Use of vibegron to treat overactive bladder
TW202629194APending Publication Date: 2026-07-16SUMITOMO PHARMA CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114138717
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-09-23
- Filing Date
- 2020-03-18
- Publication Date
- 2026-07-16
Abstract
The present disclosure is directed to a method of treating overactive bladder comprising orally administering to a subject in need thereof an amount of 75 mg of vibegron per day.
Need to check novelty before this filing date? Find Prior Art